UM

Browse/Search Results:  1-10 of 55 Help

Selected(0)Clear Items/Page:    Sort:
TNFR2-expressing CD4+ Foxp3+ regulatory T cells in cancer immunology and immunotherapy Journal article
Progress in Molecular Biology and Translational Science, 2019
Authors:  Jiang He;  Ruixin Li;  Yibo Chen;  Yuanjia Hu;  Xin Chen
Favorite  |  View/Download:7/0  |  Submit date:2019/05/08
Regulatory t Cells  Immunotherapy  Cancer  Tumor Necrosis Factor Receptor Type 2  Tumor Necrosis Factor  
A network pharmacology-based approach to analyse potential targets of traditional herbal formulas: An example of Yu Ping Feng decoction Journal article
SCIENTIFIC REPORTS, 2018,Volume: 8
Authors:  Zuo, Huali;  Zhang, Qianru;  Su, Shibing;  Chen, Qilong;  Yang, Fengqing;  Hu, Yuanjia
Favorite  |  View/Download:13/0  |  Submit date:2018/10/30
Intelligent Classifier: A Tool to Impel Drug Technology Transfer from Academia to Industry Journal article
Journal of Pharmaceutical Innovation, 2018,Page: 1-7
Authors:  Hui-Heng Lin;  Defang Ouyang;  Yuanjia Hu
Favorite  |  View/Download:4/0  |  Submit date:2019/01/23
University Patents  Patent Licensing  Machine Learning Prediction  Support Vector Machine  Pharmaceutical Patents  Technology Transfer  
Qualitative and quantitative analysis of the saponins in Panax notoginseng leaves using ultra-performance liquid chromatography coupled with time-of-flight tandem mass spectrometry and high performance liquid chromatography coupled with UV detector Journal article
JOURNAL OF GINSENG RESEARCH, 2018,Volume: 42,Issue: 2,Page: 149-157
Authors:  Liu, Fang;  Ma, Ni;  He, Chengwei;  Hu, Yuanjia;  Li, Peng;  Chen, Meiwan;  Su, Huanxing;  Wan, Jian-Bo
Favorite  |  View/Download:11/0  |  Submit date:2018/10/30
Ginsenoside Transformation  Notoginsenoside Fd  Notoginsenoside Fe  Panax Notoginseng Leaves  Uplc/q-tof Ms  
Modulation of Regulatory T Cell Activity by TNF Receptor Type II-Targeting Pharmacological Agents Journal article
FRONTIERS IN IMMUNOLOGY, 2018,Volume: 9
Authors:  Zou, Huimin;  Li, Ruixin;  Hu, Hao;  Hu, Yuanjia;  Chen, Xin
Favorite  |  View/Download:6/0  |  Submit date:2018/10/30
Tnf Receptor Type Ii  Regulatory t Cells  Tnf Receptor Type Ii Agonists  Tnf Receptor Type Ii Antagonists  Immunotherapy  
Internationalization of traditional Chinese medicine: current international market, internationalization challenges and prospective suggestions Journal article
CHINESE MEDICINE, 2018,Volume: 13
Authors:  Lin, Annie Xianghong;  Chan, Ging;  Hu, Yuanjia;  Ouyang, Defang;  Ung, Carolina Oi Lam;  Shi, Luwen;  Hu, Hao
View  |  Adobe PDF(93Kb)  |  Favorite  |  View/Download:91/1  |  Submit date:2018/10/30
Tcm  Internationalization  International Market  Quality Control  Standardization  
Research and development of anti-Alzheimer's disease drugs: an update from the perspective of technology flows Journal article
EXPERT OPINION ON THERAPEUTIC PATENTS, 2018,Volume: 28,Issue: 4,Page: 341-350
Authors:  Liu, Kunmeng;  Lin, Hui-Heng;  Pi, Rongbiao;  Mak, Shinghung;  Han, Yifan;  Hu, Yuanjia
Favorite  |  View/Download:2/0  |  Submit date:2018/10/31
Alzheimer's disease  patent  technology flow  citation network  research and development  
Research and development of anti-Alzheimer's disease drugs: an update from the perspective of technology flows Journal article
EXPERT OPINION ON THERAPEUTIC PATENTS, 2018,Volume: 28,Issue: 4,Page: 341-350
Authors:  Liu, Kunmeng;  Lin, Hui-Heng;  Pi, Rongbiao;  Mak, Shinghung;  Han, Yifan;  Hu, Yuanjia
Favorite  |  View/Download:2/0  |  Submit date:2018/10/31
Alzheimer's disease  patent  technology flow  citation network  research and development  
Research and development of anti-Alzheimer's disease drugs: an update from the perspective of technology flows Journal article
EXPERT OPINION ON THERAPEUTIC PATENTS, 2018,Volume: 28,Issue: 4,Page: 341-350
Authors:  Liu, Kunmeng;  Lin, Hui-Heng;  Pi, Rongbiao;  Mak, Shinghung;  Han, Yifan;  Hu, Yuanjia
Favorite  |  View/Download:9/0  |  Submit date:2018/10/30
Alzheimer's disease  patent  technology flow  citation network  research and development  
Trends involving monoclonal antibody (mAb) research and commercialization: A scientometric analysis of IMS Lifecycle R&D Focus Database (1980-2016) Journal article
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018,Volume: 14,Issue: 4,Page: 847-855
Authors:  Lai, Yunfeng;  Suo, Sizhuo;  Wang, Ruibing;  Kong, Xiangjun;  Hu, Yuanjia;  Tang, Daisheng;  Shi, Honghao;  Chen, Shengqi;  Hu, Hao
Favorite  |  View/Download:6/0  |  Submit date:2018/10/30
monoclonal antibody  mAb  technology commercialization  CiteSpace  IMS